Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 01, 2021
- Source ID
- 10.1016/j.jbc.2021.100382
Entities
People
- Fang-Tsyr Lin
- Joshua D. Graves
- Kang Liu
- Weei-Chin Lin
Organizations
- Baylor College of Medicine
- National Cancer Institute
- National Center for Research Resources
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- United States Department of Defense